Literature DB >> 17340091

[The current diagnostic approach for chronic progressive dementia].

C Bartels1, C W Wallesch.   

Abstract

This review presents diagnostic criteria for the different dementia syndromes and mild cognitive impairment. It is being claimed that in view of the current pharmacological interventions and after exclusion of symptomatic dementia, a controlled trial with cholinesterase inhibitors or memantine is more efficient than elaborate diagnostics. Efficiency of differential diagnosis will increase when drugs are available that specifically improve the different degenerative dementias and vascular dementia. Clinical pictures of the various dementia syndromes are briefly described.

Entities:  

Mesh:

Year:  2007        PMID: 17340091     DOI: 10.1007/s00115-006-2248-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.297


  20 in total

1.  Neurochemical features of frontotemporal dementia.

Authors:  A W Procter; M Qurne; P T Francis
Journal:  Dement Geriatr Cogn Disord       Date:  1999       Impact factor: 2.959

Review 2.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

Review 3.  Why are stroke patients prone to develop dementia?

Authors:  F Pasquier; D Leys
Journal:  J Neurol       Date:  1997-03       Impact factor: 4.849

4.  How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia.

Authors:  T Pohjasvaara; R Mäntylä; O Salonen; H J Aronen; R Ylikoski; M Hietanen; M Kaste; T Erkinjuntti
Journal:  Arch Neurol       Date:  2000-09

Review 5.  The cognitive syndrome of vascular dementia: implications for clinical trials.

Authors:  D W Desmond; T Erkinjuntti; M Sano; J L Cummings; J V Bowler; F Pasquier; J T Moroney; S H Ferris; Y Stern; P S Sachdev; V C Hachinski
Journal:  Alzheimer Dis Assoc Disord       Date:  1999 Oct-Dec       Impact factor: 2.703

6.  Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  D S Knopman; S T DeKosky; J L Cummings; H Chui; J Corey-Bloom; N Relkin; G W Small; B Miller; J C Stevens
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

7.  Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques.

Authors:  Jürgen M Peters; Thomas Hummel; Tilman Kratzsch; Jörn Lötsch; Carsten Skarke; Lutz Frölich
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

8.  Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

Authors:  John T O'Brien; Sean Colloby; John Fenwick; E David Williams; Michael Firbank; David Burn; Dag Aarsland; Ian G McKeith
Journal:  Arch Neurol       Date:  2004-06

9.  Amnestic MCI or prodromal Alzheimer's disease?

Authors:  Bruno Dubois; Martin L Albert
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

10.  A comparison of the Addenbrooke's Cognitive Examination (ACE), conventional neuropsychological assessment, and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimer's disease.

Authors:  Clare J Galton; Sharon Erzinçlioglu; Barbara J Sahakian; Nagui Antoun; John R Hodges
Journal:  Cogn Behav Neurol       Date:  2005-09       Impact factor: 1.600

View more
  2 in total

Review 1.  [Treatment and care strategies for Alzheimer's disease and related dementias].

Authors:  H Förstl
Journal:  Nervenarzt       Date:  2008-05       Impact factor: 1.214

2.  Mitochondria, cognitive impairment, and Alzheimer's disease.

Authors:  M Mancuso; V Calsolaro; D Orsucci; C Carlesi; A Choub; S Piazza; G Siciliano
Journal:  Int J Alzheimers Dis       Date:  2009-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.